Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caregiver-reported Economic Burden and Quality of Life Impact of Monocarboxylate Transporter 8 (MCT8) Deficiency

NCT06060197 is registered in ClinicalTrials.gov with Rare Thyroid Therapeutics International AB as lead sponsor.

NCT NCT06060197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caregiver-reported Economic Burden and Quality of Life Impact of Monocarboxylate Transporter 8 (MCT8) Deficiency
Lead sponsor
Rare Thyroid Therapeutics International AB
Phase
Observational
Overall status
Completed
Start date
August 23, 2022
Completion date
April 12, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allan-herndon-dudley syndrome, monocarboxylate transporter 8 (mct8) deficiency